Prostate Cancer Trial, Recruiting NCT05912764 Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT05912764
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are scheduled to have a laser procedure through a scope to remove excess prostate tissue
  • People with an enlarged prostate causing bothersome symptoms that have not improved with medication
  • People with an enlarged prostate that has led to the inability to fully empty the bladder over a long period of time
  • People with an enlarged prostate complicated by a prostate infection
  • People with an enlarged prostate causing noticeable symptoms

Who may not be able to join:

  • People who live outside the area where the trial's nursing coordination team is able to provide support
  • People who are confined to bed or who have a poor general health status (rated above level 2 on the WHO performance scale)
  • People who require ongoing blood-thinning medication that cannot be safely paused or switched to a heparin injection at home around the time of the procedure
  • People who take two types of anti-platelet (blood-clotting prevention) medications that cannot be safely paused before the procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Philippe ROUVELLAT, MD, GCS RAMSAY SANTE

Phone: + 33 5 61 37 82 93

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Registry
ClinicalTrials.gov
Start date
26 January 2024
Est. completion
15 August 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Re-hospitalizations and/or hospitalization extensions rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov